ILT tooth whitening laser placements will not be slowed by warning letter, firm says.
This article was originally published in The Gray Sheet
Executive Summary
ION LASER TECHNOLOGY'S TOOTH WHITENING CENTER EQUIPMENT PLACEMENTS will not be delayed by a recent FDA warning letter citing violations of two of its tooth-whitening lasers, the company says in a June 26 release responding to the letter. ILT says the deficiencies are relatively minor, and that FDA has indicated that the firm can continue to ship products while corrections are made.
You may also be interested in...
EU’s SCCS Finds Endocrine-Disrupting Evidence Inconclusive In UV Filter Reassessments
While endocrine-disrupting evidence was inconclusive, the Scientific Committee on Consumer Safety recommends more conservative limits on use of homosalate, octocrylene and benzophenone-3 in cosmetic products compared with current requirements under the European Cosmetics Product Regulation.
US FDA Urges COVID-19 Transmission Risk Mitigation In Cell And Gene Therapy Manufacturing
The risk of inadvertently growing SARS-CoV-2 virus in cell and gene therapies and possibly infecting patients and workers should be assessed and mitigated, the agency advises.
COVID-19: US Acted To Beat Other Countries To Next 1.25M Doses Of Regeneron Cocktail
Move was meant to preempt others’ efforts to secure the next six months of Regeneron’s COVID-19 antibody therapeutic.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: